1. Isomorphic Labs in Advanced Talks to Raise Over $2B Led by Thrive Capital
Isomorphic Labs, the AI-powered drug discovery company spun out of Google DeepMind, is in advanced discussions to raise more than $2 billion in a funding round led by Thrive Capital, according to sources familiar with the matter. The scale of the potential raise signals intensifying investor appetite for AI-driven phar...